<bill session="117" type="h" number="8038" updated="2022-12-29T17:18:47Z">
  <state datetime="2022-06-13">REFERRED</state>
  <status>
    <introduced datetime="2022-06-13"/>
  </status>
  <introduced datetime="2022-06-13"/>
  <titles>
    <title type="display">Formula Shortage Reporting Act of 2022</title>
    <title type="short" as="introduced">Formula Shortage Reporting Act of 2022</title>
    <title type="official" as="introduced">To authorize the Food and Drug Administration to require manufacturers of infant formula to warn about a discontinuance or interruption in the production of infant formula, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="J000301"/>
  <cosponsors>
    <cosponsor bioguide_id="B000740" joined="2022-06-13"/>
    <cosponsor bioguide_id="S001216" joined="2022-06-13"/>
    <cosponsor bioguide_id="S001209" joined="2022-06-13"/>
  </cosponsors>
  <actions>
    <action datetime="2022-06-13">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-06-13" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-18T15:02:02Z" status="Introduced in House">Formula Shortage Reporting Act of 2022

This bill requires manufacturers of infant formula to notify the Food and Drug Administration (FDA) at least 72 hours in advance of a manufacturing interruption or product discontinuance that is expected to meaningfully disrupt the product's supply. The FDA must post such information on its website and notify health care providers.</summary>
</bill>
